Clover Health Investments (CLOV) Net Cash Flow (2020 - 2026)

Clover Health Investments (CLOV) has 7 years of Net Cash Flow data on file, last reported at $95.0 million in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow rose 342.85% year-over-year to $95.0 million; the trailing twelve-month figure through Mar 2026 stood at $17.8 million (up 442.08% YoY), and the FY2025 full-year result was -$116.2 million, down 277.05% from the prior year.
• Net Cash Flow for Q1 2026 stood at $95.0 million, up from -$111.8 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $119.5 million in Q2 2023 and bottomed at -$297.3 million in Q4 2022.
• The 5-year median for Net Cash Flow is $24.2 million (2024), against an average of -$10.6 million.
• The widest annual swing landed in 2022, when Net Cash Flow tumbled 404.32%; it then surged 433.16% in 2023.
• A 5-year view of Net Cash Flow shows it stood at -$297.3 million in 2022, then soared by 52.51% to -$141.2 million in 2023, then surged by 67.56% to -$45.8 million in 2024, then plunged by 143.96% to -$111.8 million in 2025, then soared by 184.98% to $95.0 million in 2026.
• The last three Net Cash Flow figures came in at $95.0 million (Q1 2026), -$111.8 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.

Peer Comparison